Development of Tetrachlorophthalimides as Liver X Receptor β (LXRβ)‐Selective Agonists
Authors:
- 30 September 2016
- journal article
- research article
- Published by Wiley in ChemMedChem
- Vol. 11 (20) , 2347-2360
Abstract
Liver X receptor (LXR) agonists are candidates for the treatment of atherosclerosis via induction of ABCA1 (ATP‐binding cassette A1) gene expression, which contributes to reverse cholesterol transport (RCT) and to cholesterol efflux from the liver and intestine. However, LXR agonists also induce genes involved in lipogenesis, such as SREBP‐1c (sterol regulatory binding element protein 1c) and FAS (fatty acid synthase), thereby causing an undesirable increase in plasma and hepatic triglyceride (TG) levels. Recent studies indicate that LXRα contributes to lipogenesis in liver, and selective LXRβ activation improves RCT in mice. Therefore, LXRβ‐selective agonists are promising candidates to improve atherosclerosis without increasing plasma or hepatic TG levels. However, the ligand‐binding domains in the two LXR isoforms α/β share high sequence identity, and few LXR ligands show subtype selectivity. In this study we identified a tetrachlorophthalimide analogue as an LXRβ‐selective agonist. Structural development led to (E)‐4,5,6,7‐tetrachloro‐2‐(2‐styrylphenyl)isoindoline‐1,3‐dione (24 a), which shows potent and selective LXRβ agonistic activity in reporter gene assays. In binding assays, compound 24 a bound to LXRβ preferentially over LXRα. It also induced the expression of ABCA1 mRNA but not SREBP‐1c mRNA in cells. Compound 24 a appears to be a promising lead compound for therapeutic agents to treat atherosclerosis without the side effects induced by LXRα/β dual agonists.Keywords
Funding Information
- the Ministry of Education, Culture, Sports, Science and Technology
- Japan Society for the Promotion of Science
- Platform for Drug Discovery, Informatics, and Structural Life Science
This publication has 32 references indexed in Scilit:
- Liver X receptor in cholesterol metabolismJournal of Endocrinology, 2009
- Expression of the liver X receptor α and β in embryonic and adult miceThe Anatomical Record Part A: Discoveries in Molecular, Cellular, and Evolutionary Biology, 2004
- Stimulation of Cholesterol Excretion by the Liver X Receptor Agonist Requires ATP-binding Cassette Transporters G5 and G8Journal of Biological Chemistry, 2003
- Synthetic LXR ligand inhibits the development of atherosclerosis in miceProceedings of the National Academy of Sciences, 2002
- Regulation of ATP-binding Cassette Sterol Transporters ABCG5 and ABCG8 by the Liver X Receptors α and βJournal of Biological Chemistry, 2002
- Direct and Indirect Mechanisms for Regulation of Fatty Acid Synthase Gene Expression by Liver X ReceptorsJournal of Biological Chemistry, 2002
- Characterization of the Human ABCG1 GeneJournal of Biological Chemistry, 2001
- Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXRαProceedings of the National Academy of Sciences, 2000
- Structural requirements of ligands for the oxysterol liver X receptors LXRα and LXRβProceedings of the National Academy of Sciences, 1999
- Activation of the Nuclear Receptor LXR by Oxysterols Defines a New Hormone Response PathwayJournal of Biological Chemistry, 1997